[HTML][HTML] SFTPA2 Mutations in Familial and Sporadic Idiopathic Interstitial Pneumonia

CHM van Moorsel, L Ten Klooster… - American journal of …, 2015 - atsjournals.org
Idiopathic interstitial pneumonias (IIPs) are diffuse lung diseases of unknown cause and high
mortality. Up to 20% of patients with IIP report having one or more family members with the …

Effect of M uc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias

…, R Snetselaar, KM Kazemier, L ten Klooster… - …, 2016 - Wiley Online Library
Background and objective A common polymorphism in the MUC5B gene (rs35705950) is
associated with susceptibility to idiopathic pulmonary fibrosis ( IPF ) and familial interstitial …

Ten-year survival in patients with idiopathic pulmonary fibrosis after lung transplantation

L Ten Klooster, GD Nossent, JM Kwakkel-van Erp… - Lung, 2015 - Springer
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrosing lung
disease with a median survival of approximately 3 years after diagnosis. The only medical …

Hoge sterfte van patiënten met idiopathische pulmonale fibrose op Nederlandse longtransplantatiewachtlijst

L ten Klooster, CHM van Moorsel… - Nederlands Tijdschrift …, 2012 - research.rug.nl
Ten tijde van de dataverzameling hadden 122 IPF-patiënten … vanwege de kleine aantallen
patiënten berekenden we dit niet… Ten eerste waren in de fase van aanmelding 36 van de 289 (…

Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre

L ten Klooster, C Theodorou, V Wilson, K Selby… - 2017 - Eur Respiratory Soc
Liesbeth ten Klooster, Chloe Theodorou, Vicky Wilson, Karen Selby, Ruth Newton, Saurabh
Gandhi, Tessa Bonnett, Joanne Fletcher, Iain Armstrong, Lisa Martin, Neil Hamilton, Gary …

Mortality in idiopathic pulmonary fibrosis (IPF) on the waiting list for lung transplantation in the Netherlands

L ten Klooster, C van Moorsel, D van Kessel… - 2011 - Eur Respiratory Soc
Background: Idiopathic Pulmonary Fibrosis (IPF) is a progressive disease with a poor prognosis
of 2.5 to 5 years. IPF is not responsive to medicinal treatment and lung transplantation is …

Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis

L ten Klooster, C van Moorsel, D van Kessel, EJ Oudijk… - 2013 - Eur Respiratory Soc
OBJECTIVE Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing lung disease with
a median survival of approximately 3 years after diagnosis. The only medical option to …

High mortality in patients with idiopathic pulmonary fibrosis on Dutch lung transplant waiting list

L ten Klooster, CH van Moorsel, PT van Hal… - Nederlands Tijdschrift …, 2012 - europepmc.org
Objective To describe patients diagnosed with idiopathic pulmonary fibrosis (IPF) registered
for lung transplantation and to evaluate the current referral guidelines for lung …

Stopping tumor necrosis factor inhibitor treatment in patients with established rheumatoid arthritis in remission or with stable low disease activity: a pragmatic …

…, HE Vonkeman, PM Ten Klooster… - Arthritis & …, 2016 - Wiley Online Library
Objective Tumor necrosis factor inhibitor (TNFi) biologic agents are an effective treatment
for rheumatoid arthritis (RA). It is unclear whether patients whose disease is in remission or …

[CITATION][C] Pulmonary hypertension and pregnancy

L ten Klooster, VJ Wilson, R Newton, K Selby… - Respiratory Disease in …, 2020